| 1 |
Andrew Skurdal |
Sdi Technologies |
5 |
| 2 |
Michael P. Galligan |
Basf Se |
2 |
| 2 |
Kathleen M. Rupprecht |
Merck |
2 |
| 2 |
Michael L. Turini |
Schering |
2 |
| 2 |
Aaron H. Leeman |
Merck |
2 |
| 2 |
Jose S. Duca |
Schering |
2 |
| 2 |
William G. Lester |
AT&T |
2 |
| 2 |
Robert K. Baker |
Merck |
2 |
| 2 |
Julia Hirschberg |
AT&T |
2 |
| #10 |
Daniel Seth Morris |
Braingate Co. |
1 |
| #10 |
Frank Bennett |
Schering |
1 |
| #10 |
Michael Charles Schlichting |
— |
1 |
| #10 |
Hal Fidlow |
— |
1 |
| #10 |
Dann Parker |
Merck |
1 |
| #10 |
Kurt W. Saionz |
Pharmacopeia Drug Discovery |
1 |
| #10 |
David John Salgueiro |
Cooper Technologies |
1 |
| #10 |
Terry J. Burkhardt |
ExxonMobil |
1 |
| #10 |
Jeffrey McFadden |
Unknown |
1 |
| #10 |
Guizhen Dong |
Merck |
1 |
| #10 |
John Frank Zamorski |
Stepan |
1 |
| #10 |
Patrick A. Autilio |
HP |
1 |
| #10 |
John Vincent Calienni |
Novartis Ag |
1 |
| #10 |
Kenneth A. Thomas, Jr. |
Merck |
1 |
| #10 |
Mark Salerno |
C Technologies |
1 |
| #10 |
Nancy-Ellen Haynes |
Hoffmann-La Roche |
1 |
| #10 |
Adam Louis Buchsbaum |
AT&T |
1 |
| #10 |
Raphael A. Monsanto |
University of Michigan |
1 |
| #10 |
Melanie Tellers |
Novartis Vaccines And Diagnostics |
1 |
| #10 |
John Didzbalis |
Mars, Incorporated |
1 |
| #10 |
Anne E. Allen |
New York Stock Exchange |
1 |